Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1891935 | chr1:3694795 | C/T | 0.000161 | 176 | 24.7 | 36.73 | 2.3 | KM Plot |
PCPG | rs189327630 | chr9:86486002 | T/A | 0.000126 | 175 | 26.57 | 24.7 | 14.47 | KM Plot |
PCPG | rs190514460 | chr7:158651529 | C/T | 0 | 176 | 25.53 | 19.83 | 3.17 | KM Plot |
PCPG | rs190638559 | chr7:1110505 | C/T | 0.000278 | 172 | 25.53 | 25.4 | 49.58 | KM Plot |
PCPG | rs1913635 | chr3:80557195 | T/C | 2.79E-5 | 177 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs1914055 | chr3:80581780 | C/A | 7.21E-5 | 175 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs1914056 | chr3:80581756 | A/G | 7.16E-5 | 175 | 19.53 | 24.77 | 27.2 | KM Plot |
PCPG | rs191665329 | chr7:105160767 | G/A | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |
PCPG | rs192026667 | chr12:56724333 | C/T | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs192353706 | chr7:158676826 | C/G | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs1924419 | chr13:37530823 | A/G | 0.00032 | 176 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs1924420 | chr13:37530840 | A/T | 0.000348 | 174 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs1924422 | chr13:37540214 | G/A | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs1924426 | chr13:37609725 | C/T | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1951898 | chr13:37506819 | A/G | 0.000434 | 175 | 6.37 | 24.7 | 25.53 | KM Plot |